Slide background

> Our Technology

DCVax® is a platform
technology that uses
activated dendritic cells

Slide background

> Our Products

DCVax® – L
DCVax® – Direct
DCVax® – Prostate

Slide background

Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers.

DCVax-L Patients From UCLA

UCLA Department of Neurosurgery

Dr. Linda Liau discusses our DCVax-L clinical trial for glioblastoma brain cancer and describes the positive impact it has had on patients. Brad and Jennifer share their stories about diagnosis and their choice to receive DCVax.